Rohit Reejsinghani - New York Ex Director
| BBAL Stock | USD 0.0001 0.00 0.00% |
Insider
Rohit Reejsinghani is Ex Director of New York Health
| Address | 33 West Hawthorne Avenue, Valley Stream, NY, United States, 11580 |
| Phone | 718-375-6700 |
| Web | https://www.nyhc.com |
New York Management Efficiency
The company has return on total asset (ROA) of 0.0364 % which means that it generated a profit of $0.0364 on every $100 spent on assets. This is way below average. New York's management efficiency ratios could be used to measure how well New York manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is expected to rise to 0.45 this year, although the value of Return On Tangible Assets will most likely fall to (0.12). At this time, New York's Total Assets are quite stable compared to the past year. Other Current Assets is expected to rise to about 156.3 K this year, although the value of Intangible Assets will most likely fall to about 537 K.Management Performance
| Return On Asset | 0.0364 |
New York Health Leadership Team
Elected by the shareholders, the New York's board of directors comprises two types of representatives: New York inside directors who are chosen from within the company, and outside directors, selected externally and held independent of New. The board's role is to monitor New York's management team and ensure that shareholders' interests are well served. New York's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, New York's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nellie KelnerPadalka, Scientific Founder | ||
| Murray Englard, Chief Director | ||
| David Katz, Co Sec | ||
| Rohit Reejsinghani, Ex Director |
New Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is New York a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0364 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 335.37 K | ||||
| Price To Earning | 0.01 X | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 44.4 M | ||||
| Gross Profit | 7.35 M | ||||
| EBITDA | 1.04 M | ||||
| Net Income | (1.05 M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in New York Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. If investors know New will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about New York listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between New York's value and its price as these two are different measures arrived at by different means. Investors typically determine if New York is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, New York's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.